Atypical pneumonias: Current clinical concepts focusing on Legionnaires' disease

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 3, 2008, Pages 183-194

  Cunha, Burke A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Chlamydophilia pneumoniae; Clinical diagnosis of atypical community acquired pneumonias; Legionella; Legionnaires' disease; Mycoplasma pneumoniae; Nonspecific laboratory findings in atypical community acquired pneumonias; Psittacosis; Q fever; Tularemia

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; MACROLIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; TELITHROMYCIN; TETRACYCLINE;

ANTIMICROBIAL THERAPY; ASTHMA; CENTRAL NERVOUS SYSTEM DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC FATIGUE SYNDROME; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMPREHENSION; CONCEPT ANALYSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE TRANSMISSION; EMPIRICISM; ENDOCARDITIS; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; LABORATORY; LABORATORY TEST; LEGIONELLA; LEGIONNAIRE DISEASE; MONOTHERAPY; MULTIPLE SCLEROSIS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; PHYSICIAN; Q FEVER; RADIODIAGNOSIS; REVIEW; TULAREMIA; VIRUS PNEUMONIA;

HUMANS; LEGIONNAIRES' DISEASE; PNEUMONIA, BACTERIAL;

EID: 42449105780     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282f79678     Document Type: Review

References (96)

1. Cunha BA, editor. Pneumonia essentials. 2nd ed. Royal Oak, Michigan: Physicians Press; 2008.
2. File TH Jr, Tan JS, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophilia in respiratory infection. Infect Dis Clin North Am 1998; 12:569-592.
3. Cosentini R, Tarsia P, Blasi F, et al. Community acquired pneumonia: role of atypical pathogens. Monaldi Arch Chest Dis 2001; 56:527-534.
4. Cunha BA. Ambulatory community-acquired pneumonia: the predominance of atypical pathogens. Eur J Clin Microbiol Infect Dis 2003; 22:579-583.
5. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect 2006; 12:12-24.
6. Sohn JW, Park SC, Choi YH, et al. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multicenter study. J Korean Med Sci 2006; 21:602-607.
7. Schneeberger PM, Dorigo-Zetsma JW, van der Zee A, et al. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand J Infect Dis 2004; 36:269-273.
8. Cotton LM, Strampfer MJ, Cunha BA. Legionella and Mycoplasma pneumoniae: a community hospital experience. Clin Chest Med 1987; 8:441-453.
9. Cunha BA, Quintiliani R. The atypical pneumonias, a diagnostic and therapeutic approach. Postgrad Med 1979; 66:95-102.
10. Johnson DH, Cunha BA. Clinical and extrapulmonary features of Chlamydia, Mycoplasma, and Legionella infections. Postgrad Med 1993; 93: 69-72.
11. Cunha F BA. Atypical pneumonias. In: Conn RD, Borer WZ, Snyder JW, editors. Current diagnosis. vol. 9. Saunders: Philadelphia; 1996.
12. Cunha BA, Ortega AM. Atypical pneumonia. Extrapulmonary clues guide the way to diagnosis. Postgrad Med 1996; 99:123-128.
13. Sopena N, Sabria-Leal M, Pedro-Botet ML, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest 1998; 113:1195-1200.
14. Miyashita N, Fukano H, Yoshida K, et al. Is it possible to distinguish between atypical pneumonia and bacterial pneumonia? Evaluation of the guidelines for community acquired pneumonia in Japan. Respir Med 2004; 98:952-960.
15. Sopena N, Pedro-Botet ML, Sabria M, et al. Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae. Scand J Infect Dis 2004; 36:330-334.
16. Masiá M, Gutiérrez F, Padilla S, et al. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect 2007; 13:153-161.
17. Cunha BA. Clinical diagnosis of Legionnaires' disease. Semin Respir Infect 1998; 13:116-127.
18. Miyashita N, Fukano H, Mouri K, et al. Self-limiting pneumonia due to Chlamydia pneumoniae. Intern Med 2005; 44:870-874.
19. Miyashita N, Saito A, Kohno S, et al. Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study. Intern Med 2002; 41:943-949.
20. Hsu MC, Lin TM, Huang CT, et al. Chlamydia pneumoniae respiratory infections in Taiwan. Microbiol Immunol 2007; 51:539-542.
21. Marrie TJ, Peeling RW, Reid T, De Carolis E, Canadian Community-Acquired Pneumonia Investigators. Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003; 21:779-784.
22. Wellinghausen N, Straube E, Freidank H, et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol 2006; 296:485-491.
23. Cunha BA. Severe community acquired pneumonia. Crit Care Clin 1998; 8:105-117.
24. Cunha BA. Severe community-acquired pneumonia: determinants of severity and approach to therapy. Infect Med 2005; 22:53-58.
25. Cunha BA. Severe community acquired pneumonia in the CCU. In: Cunha BA, editor. Infectious diseases in critical care medicine, 2nd ed. Informa Healthcare: New York; 2007.
26. Coletta FS, Fein AM. Radiological manifestation of Legionella/Legionella- like organisms. Semin Respir Infect 1998; 13:109-115.
27. Boermsa WG, Daniels JM, Lowernberg A, et al. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006; 100:926-932.
28. Sugihara E, Dambara T, Aiba M, et al. Clinical characteristics of 8 sporadic cases of community-acquired Legionella pneumonia in advanced age. Intern Med 2007; 46:461-465.
29. Cunha BA, Pherez FM. Bilateral spontaneous pneumothoraces at the presenting finding in Legionnaires' disease. Heart Lung (in press).
30. Sakai F, Tokuda H, Goto H. Computed tomographic features of Legionella pneumophilia pneumonia in 38 cases. Comput Assist Tomogr 2007; 31:125-131. The "ground glass" appearance of Legionnella is a useful computed tomography finding.
31. Nambu A, Saito A, Araki T, et al. Chlamydia pneumoniae: comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT. Radiology 2006; 238:330-338.
32. Okada F, Ando Y, Wakisaka M, Matsumoto S, Mori H. Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings. J Comput Assist Tomogr 2005; 29:626-632.
33. Lee I, Kim TS, Yoon HK. Mycoplasma pneumoniae pneumonia: CT features in 16 patients. Eur Radiol 2006; 16:719-725.
34. Cunha BA. Diagnostic significance of relative bradycardia. Clin Microbiol Infect Dis 2000; 6:633-634.
35. Kulkarni KH, Thorat SB, Wagle SC, et al. Focal neurological manifestations in Legionellosis. J Assoc Phys India 2005; 53:731-733.
36. Kofteridis DP, Mazokopakis EE, Tselentis Y, Gikas A. Neurological complications of acute Q fever infection. Eur J Epidemiol 2004; 19:1051-1054.
37. Sotgiu S, Pugliatti M, Rosati G, et al. Neurological disorders associated with Mycoplasma pneumoniae infection. Eur J Neurol 2003; 10:165-168.
38. Völter C, Helms J, Weissbrich B, et al. Frequent detection of Mycoplasma pneumoniae in Bell's palsy. Eur Arch Otorhinolaryngol 2004; 261:400-404.
39. Cunha BA. Community-acquired pneumonia: diagnostic and therapeutic considerations. Med Clin North Am 2001; 85:43-77.
40. Cutler SJ, Bouzid M, Cutler RR. Q fever. J Infect 2007; 54:313-318.
41. Cholongitas E, Zouli C, Pipili C, et al. Coxiella burnetii and lobar pneumonia. South Med J 2006; 99:1309-1310.
42. Cunha BA. Diagnostic significance of non-specific laboratory tests in infectious diseases. In: Gorbach SL, Bartlett JB, Blacklow NR, editors. Infectious diseases in medicine and surgery, 3rd ed. Saunders: Philadelphia; 2002. pp. 116-127.
43. Cunha BA. Hypophosphatemia: diagnostic significance in Legionnaires' disease. Am J Med 2006; 119:5-6.
44. Cunha BA. Elevated serum transaminases in patients with Mycoplasma pneumoniae pneumonia. Clin Microbiol Infect 2005; 11:1051-1052.
45. Franzin L, Cabodi D. Legionella pneumonia and serum procalcitonin. Curr Microbiol 2005; 50:43-46.
46. Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest 2001; 120:1049-1053.
47. Cunha BA. Severe Legionella pneumonia: rapid diagnosis with Winthrop-University Hospital's Weighted Point Score System (Modified). Heart Lung (in press).
48. Cunha BA. Antibiotic pharmacokinetic considerations in pulmonary infections. Semin Respir Infect 1991; 6:168-182.
49. Hyde TB, Gilbert M, Schwartz SB, et al. Azithromycin prophlyaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis 2001; 183:907-912.
50. Cunha BA. Tularemia. In: Kass E, Platt R, editors. Current therapy in infectious therapy in infectious disease. Philadelphia: BC Decker; 1990. pp. 330-331.
51. Cunha BA, editor. Antibiotic essentials. 7th ed. Royal Oak, MI: Physicians Press; 2008.
52. Baltch AL, Bopp LH, Smith RP, et al. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. J Antimicrob Chemother 2005; 56:104-109.
53. Hendrickson SE, Neil M. Legionella pneumonia and HIV infection: a case report. AIDS Read 2004; 14:267-270.
54. Rudin JE, Evans TL, Wing EJ. Failure of erythromycin in treatment of Legionella micdadei pneumonia. Am J Med 1984; 76:318-320.
55. Parker MM, Macher AM, Shelhamer JH, et al. Unresponsiveness of Legionella bozemanii pneumonia to erythomcyin administration despite in vitro sensitivity. Am Rev Respir Dis 1983; 182:955-956.
56. Grau S, Antonio JM, Ribes E, et al. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia. Int J Antimicrob Agents 2006; 28:249-252.
57. Mercatello A, Frappaz D, Robert D, et al. Failure of erythromycin/rifampicin treatment of Legionella pneumonia. J Infect 1985; 10:282-283.
58. Haranaga S, Tateyama M, Higa F, et al. Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia. Intern Med 2007; 46:353-357.
59. Blázquez Garrido RM, Espinosa Parra FJ, Alemany Francés L, et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin Infect Dis 2005; 41:416-417.
60. Mykietiuk A, Carratal J, Fernandex-Sabe N, et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis 2005; 15:794-799.
61. Sabrià M, Pedro-Botet ML, Gómez J, et al., Legionnaires Disease Therapy Group. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest 2005; 128:1401-1405.
62. Marrie TJ. Q fever pneumonia. Curr Opin Infect Dis 2004; 17:137-142.
63. Parker NR, Barralet JH, Bell AM. Q fever. Lancet 2006; 367:679-688.
64. Tompkins LS, Roessier BJ, Redd SC, et al. Legionella prosthetic-valve endocarditis. N Engl J Med 1988; 318:530-535.
65. Brusch J, editor. Infectious endocarditis. New York: Informa Healthcare; 2007.
66. Sutherland ER, Brandorff JM, Martin RJ. Atypical bacterial pneumonia and asthma risk. J Asthma 2004; 41:863-868.
67. Nisar N, Guleria R, Kumar S, et al. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007; 83:100-104. A good review of the relationship between M. pneumoniae and asthma.
68. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000; 16:1142-1146.
69. Meloni F, Paschetto E, Mangiarotti P, et al. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother 2004; 16:70-76.
70. Diederen BM, van der Valk PD, Kluytmans JA, et al. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 30:240-244.
71. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995; 30:121-128.
72. Romano Carratelli C, Nuzzo I, Cozzolino D, et al. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Int Immunopharmacol 2006; 6:848-853.
73. Buljevac D, Verkooyen RP, Jacobs BC, et al. Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Ann Neurol 2003; 54:828-831.
74. Sanford JP. Tularemia. JAMA 1983:3225-3226.
75. Teutsch SM, Martone WJ, Brink EW, et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med 1979; 301:826-828.
76. Liles WC, Burger RJ. Tularemia from domestic cats. West J Med 1993; 158:619-622.
77. Kirchner JT. Psittacosis. Is contact with birds causing your patient's pneumonia? Postgrad Med 1997; 102:181-182.
78. Gregory DW, Schaffner W. Psittacosis. Semin Respir Infect 1997; 12: 7-11.
79. Sopena N, Force L, Pedro-Botet ML, et al. Sporadic and epidemic community legionellosis: two faces of the same illness. Eur Respir J 2007; 29:138-142.
80. Hugosson A, Hjorth M, Bernander S, et al. A community outbreak of Legionnaires' disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures. Scand J Infect Dis 2007; 39:217-224.
81. Nguyen TM, Ilef D, Jarraud S, et al. A community-wide outbreak of legionnaires disease linked to industrial cooling towers: how far can contaminated aerosols spread? J Infect Dis 2006; 193:102-111.
82. Payne L, Andersson Y, Ledet Muller L, et al. Outbreak of Legionnaires' disease among tourists staying at a hotel in Phuket, Thailand. Euro Surveill 2007; 12:E070111.2.
83. den Boer JW, Yzerman EP, Jansen R, et al. Legionnaires' disease and gardening. Clin Microbiol Infect 2007; 13:88-91. Another potential source of Legionnaires' disease.
84. McDonough EA, Metzgar D, Hansen CJ, et al. A cluster of Legionella-associated pneumonia cases in a population of military recruits. J Clin Microbiol 2007; 45:2075-2077.
85. Levy PY, Teysseire N, Etienne J, et al. A nosocomial outbreak of Legionella pneumophila caused by contaminated transesophageal echocardiography probes. Concise Commun 2004; 24:619-622.
86. Sabria, Pedro-Botet ML, Gomez J, et al. Flouroquinolones vs macrolides in the treatment of Legionnaires' disease. Chest 2005; 128:1401-1405.
87. Pedro-Botet L, Yu VL. Legionella: macrolides or quinolones? Clin Microbiol Infect 2006; 12:25-30.
88. Tubach F, Ravud P, Salmon-Céron D, et al., Recherce Axée sur la Tolérance des Biothérapies Group. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis 2006; 43:e95-e100.
89. Alis E, Boufas A, Iliopoulos I, et al. Severe community-acquired pneumonia with acute hypoxemic respiratory failure due to primary infection with Chlamydia pneumoniae in a previously healthy adult. Clin Infect Dis 2003; 36:155-157.
90. Hummel M, Hofheinz R, Buchheidt D. Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. Ann Hematol 2004; 83:441-443.
91. Glanville AR, Gencay M, Tamm M, et al. Chlamydia pneumoniae infection after lung transplantation. J Heart Lung Transplant 2005; 24:131-136.
92. Antón E. A frequent error in etiology of round pneumonia. Chest 2004; 125:1592-1593.
93. Nausheen S, Cunha BA. Q fever in community-acquired pneumonia in a patient with Crohn's disease on immunosuppressive therapy. Heart Lung 2007; 36:300-303. Q fever CAP is an easily overlooked diagnosis.
94. Hamzic S, Beslagic E, Zvizdic S. Significance of Q fever serologic diagnosis in clinically suspect patients. Ann NY Acad Sci 2003; 18:183-195.
95. Nakashima K, Tanaka T, Kramer MH, et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect Control Hosp Epidemiol 2006; 27:1171-1177.
96. Phares CR, Russell E, Thigpen MC, et al. Legionnaires' disease among residents of a long-term care facility: the sentinel event in a community outbreak. Am J Infect Control 2007; 5:319-323. Legionella is often overlooked as a cause of NHAP outbreaks.